News

ERC - Results Consolidator grants 2019 call

Published on | 5 years ago

Programmes ERC

The evaluation results of the 2019 Consolidator grant call have been announced by ERCEA. 301 applications are eligible for funding out of a total of 2453 applications submitted. Among the 301 Principle Investigators are 4 PIs affiliated with a Flemish host institution.

  • Kim de Keersmaecker, Katholieke Universiteit Leuven, “Silent - Silent mutations in cancer”, LS4
  • Clement Merckling, Interuniversitair Micro-Electronica Centrum, ”Notice - Novel Oxides and Topological Interfaces for quantum Computing Electronics”, PE7
  • Moritz Nowack, Vlaams instituut voor Biotechnologie, “Execut.er - Dissecting the molecular mechanisms that execute developmental programmed cell death in plants”, LS3
  • Koen Vandewal, Universiteit Hasselt, “Control - Charge-TRansfer states for high-performance Organic eLecetronics”, PE4

ERCEA press release

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1712 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.